NewcelX Ltd
NCEL
3 hedge funds and large institutions have $263K invested in NewcelX Ltd in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.05% less ownership
Funds ownership: 0.45% → 0.4% (-0.05%)
25% less funds holding
Funds holding: 4 → 3 (-1)
44% less capital invested
Capital invested by funds: $467K → $263K (-$204K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$32.8K |
| 2 |
Morgan Stanley
New York
|
-$7.28K |
NCEL Hedge Fund Activity: Q3 2025 in Review
3 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in NewcelX Ltd (NCEL) for Q3 2025, worth a combined $263K — down 44% from $467K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NCEL and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $32.8K.
- 3 institutional investors held NewcelX Ltd (NCEL) as of Q3 2025, down from 4 in Q2 2025.
- Funds reported $263K of NewcelX Ltd stock for Q3 2025, down 44% quarter-over-quarter.
- 0 funds opened new NewcelX Ltd positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest NewcelX Ltd seller in Q3 2025 was UBS Group, an estimated $32.8K sold.
Based on aggregated 13F filings for Q3 2025.